Drug Pipeline

Cobicistat Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 2/3
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06337032 A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have… HIV-1-infection Recruiting
Phase 2/3
NCT02016924 Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co)… Acquired Immune Deficiency Syndrome (AIDS) Active, Not Recruiting
Phase 1/2
NCT04065399 A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene… Acute Myeloid Leukemia Recruiting
Sponsors Running Cobicistat Trials
Gilead Sciences (2) Syndax Pharmaceuticals (1)
Disease Areas
Leukemia (1) Acute Myeloid Leukemia (AML) (1) Acute Lymphoblastic Leukemia (ALL) (1)
Get alerts when Cobicistat trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free